Moderna announces global regulatory submissions for its respiratory syncytial virus (RSV) vaccine, mRNA-1345

5 July 2023 - Moderna has submitted marketing authorization applications for the investigational RSV vaccine, mRNA-1345, with the European Medicines Agency, ...

Read more →

FDA approves drugs before EMA and Swissmedic, comparison finds

23 February 2018 - From 2007 to 2016, the US FDA approved more new drugs and biologics first than its ...

Read more →